Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

ImmunoPrecise Antibodies advances development of PolyTope for SARS-CoV-2

Dec. 1, 2021

Arbutus Biopharma synthesizes new HBV and HDV antivirals

Dec. 1, 2021

Quretech Bio presents compounds for Gram-positive bacterial infections

Dec. 1, 2021

NHD2 is essential in Leishmania independently of complex I, emerging as a potential drug target

Nov. 30, 2021

Indomethacin-based PROTACs show pan-coronavirus activity, including SARS-CoV-2 strains

Nov. 30, 2021

Polyphenylene carboxymethylene shows anti-SARS-CoV-2 activity in vitro

Nov. 30, 2021

Discovery of novel antifungal compounds with improved metabolic stability

Nov. 30, 2021

B-cell targeting controls chronic viral infections in mice

Nov. 30, 2021

Compounds targeting NPC1 protein show promising antiviral activity against SARS-CoV-2

Nov. 26, 2021

Sinocelltech patents Fc fragment fusion protein glycoconjugates

Nov. 26, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...